- Home
- NMAI vs NRC Comparison
NMAI vs NRC Comparison
Compare NMAI & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMAI | NRC |
|---|---|---|
| Founded | 2021 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 429.9M | 278.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NMAI | NRC |
|---|---|---|
| Price | $12.97 | $18.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 74.8K | ★ 92.1K |
| Earning Date | 01-01-0001 | 01-26-2026 |
| Dividend Yield | ★ 13.14% | 3.37% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.64 | ★ 0.71 |
| Revenue | N/A | ★ $139,102,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $19.03 | $26.78 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.60 | $9.76 |
| 52 Week High | $12.55 | $19.39 |
Technical Indicators
Market Signals| Indicator | NMAI | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 50.05 | 69.97 |
| Support Level | $12.75 | $18.50 |
| Resistance Level | $13.01 | $19.20 |
| Average True Range (ATR) | 0.15 | 0.74 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 41.38 | 92.15 |
Price Performance
Historical ComparisonAbout NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.